• 1
    Steer P. The epidemiology of preterm labour. BJOG 2005; 112: 13.
  • 2
    Goffinet F. Primary predictors of preterm labour. BJOG 2005; 112: 3847.
  • 3
    Perroni AG, Bittar RE, Fonseca ESVB, Messina ML, Marra KC, Zugaib M. Prematuridade eletiva: aspectos obstetricos e perinatais. Rev Ginec Obstet 1999; 10: 6771.
  • 4
    Iams JD, Goldenberg RL, Mercer BM, Moawad A, Thom E, Meis PJ, McNellis D, Caritis SN, Miodovnik M, Menard MK, Thurnau GR, Bottoms SE, Roberts JM. The preterm prediction study: recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1998; 178: 10351040.
  • 5
    Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991; 325: 669674.
  • 6
    Lockwood CJ. Biochemical predictors of prematurity. Front Horm Res 2001; 27: 258268.
  • 7
    Bittar RE, Yamasaki AA, Sasaki S, Zugaib M. Cervical fetal fibronectin in patients at increased risk for preterm delivery. Am J Obstet Gynecol 1996; 175: 178181.
  • 8
    Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, McNellis D, Copper RL, Johnson F, Roberts JM. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med 1996; 334: 567572.
  • 9
    Carvalho MHB, Bittar RE, Brizot ML, Maganha PPS, Borges da Fonseca ESV, Zugaib M. Cervical length at 11–14 weeks' and 22–24 weeks' gestation evaluated by transvaginal sonography, and gestational age at delivery. Ultrasound Obstet Gynecol 2003; 21: 135139.
  • 10
    de Carvalho MHB, Bittar RE, Brizot M de L, Bicudo C, Zugaib M. Prediction of preterm delivery in the second trimester. Obstet Gynecol 2005; 105: 532536.
  • 11
    Giudice LC, Irwin JC. Roles of the insulin-like growth factor family in nonpregnant human endometrium and at the decidua: trophoblast interface. Semin Reprod Endocrinol 1999; 17: 1321.
  • 12
    Kurkinen-Raty M, Ruokonen A, Vuopala S, Koskela M, Rutanen E, Karkkainen T, Jouppila P. Combination of cervical interleukin-6 and -8, phosphorylated insulin-like growth factor-binding protein-1 and transvaginal cervical ultrasonography in assessment of the risk of preterm birth. BJOG 2001; 108: 875881.
  • 13
    Kekki M, Kurki T, Karkkainen T, Hiilesmaa V, Paavonen J, Rutanen EM. Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand 2001; 80: 546551.
  • 14
    Lembet A, Eroglu D, Ergin T, Kuscu E, Zeyneloglu H, Batioglu S, Haberal A. New rapid bed-side test to predict preterm delivery: phosphorylated insulin-like growth factor binding protein-1 in cervical secretions. Acta Obstet Gynecol Scand 2002; 81: 706712.
  • 15
    Kwek K, Khi C, Ting HS, Yeo GS. Evaluation of a bedside test for phosphorylated insulin-like growth factor binding protein-1 in preterm labour. Ann Acad Med Singapore 2004; 33: 780783.
  • 16
    Sonek J, Shellhaas C. Cervical sonography: a review. Ultrasound Obstet Gynecol 1998; 11: 7178.
  • 17
    Heath VCF, Southall TR, Souka AP, Elisseou A, Nicolaides KH. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 1998; 12: 312317.
  • 18
    Crowther CA. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database Syst Rev 2005, Issue 1.
  • 19
    Drakeley AJ, Roberts D, Alfirevic Z. Cervical cerclage for prevention of preterm delivery: meta-analysis of randomized trials. Obstet Gynecol 2003; 102: 621627.
  • 20
    To MS, Alfirevic Z, Heath VC, Cicero S, Cacho AM, Williamson PR, Nicolaides KH. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet 2004; 363: 18491853.
  • 21
    da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419424.
  • 22
    Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S; National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 23792385.
  • 23
    ACOG. ACOG Committee Opinion. Use of progesterone to reduce preterm birth. Obstet Gynecol 2003; 102: 11151116.
  • 24
    Rutanen E-M, Karkkainen T, Lundqvist C. Monoclonal antibodies to the 27–34K insulin-like growth factor binding protein. Biochem Biophys Res Commun 1988; 152: 208215.
  • 25
    Akercan F, Kazandi M, Sendag F, Cipran T, Mgoyi T, Terek MC, Sagol S. Value of cervical phosphorylated insulin-like growth factor binding protein-1 in the prediction of preterm labor. J Reprod Med 2004; 49: 368372.
  • 26
    Elizur SE, Yimon Y, Epstein GS, Seidman DS, Schiff E, Sivan E. Insulin-like growth factor binding protein-1 detection in preterm labor: evaluation of a bedside test. Am J Perinatol 2005; 22: 305309.